Dissociation of LPS-induced monocytic ex vivo production of granulocyte colony-stimulating factor (G-CSF) and TNF-α in patients with septic shock

Cytokine

Volumn 13, Issue 1, 2001, Pages 51-54

  Weiss, Manfred ^a   Fischer, Guenther ^a   Barth, Eberhard ^a   Boneberg, Eva ^b   Schneider, Elisabeth Marion ^a   Georgieff, Michael ^a   Hartung, Thomas ^a  

^a Universitaetsklinikum ^*  (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Granulocyte colony stimulating factor; LPS; Sepsis; Septic shock; TNF

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEATH; DISSOCIATION; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVAL RATE;

EID: 0035819239     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0796     Document Type: Article

References (22)

1. Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome
2. In vivo endotoxin tolerance: Impaired LPS-stimulated TNF release of monocytes from patients with sepsis, but not SIRS
3. Dysregulation of in vitro cytokine production by monocytes during sepsis
4. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin
5. Control of fecal peritoneal infection in mice by colony-stimulating factors
6. Ex vivo neutrophil function in response to three different doses of glycosylated rHuG-CSF (Lenograstim)
7. Effects of in vivo administration of G-CSF on neutrophil functions in healthy volunteers
8. Levels of serum granulocyte colony-stimulating factor in patients with infections
9. Levels of human serum granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor under pathological conditions
10. Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections
11. The prognostic value of serum cytokine levels in patients with acute infections
12. Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis
13. Dynamics of blood cytokine concentrations in patients with bacteremic infections
14. Evaluation of recombinant human granulocyte colony-stimulating factor (rhG-CSF) therapy in granulopoetic patients complicated with sepsis
15. Filgrastim (rhG-CSF) related modulation of the inflammatory response in patients at risk of sepsis or with sepsis
16. Granulocyte colony-stimulating factor to prevent the progression of systemic non-responsiveness in SIRS and sepsis
17. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
18. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers
19. Filgrastim (r-metHuG-CSF) restores IL-2 production of blood from advanced HIV patients
20. Blood cytokine response of low dose Molgramostim (rhGM-CSF) treated patients
21. Inflammatory and immunological parameters in children with hemolytic uremic syndrome (HUS) and gastroenteritis-pathophysiological and diagnostic clues
22. Human monocytes express functional receptors for granulocyte colony-stimulating factor